GlaxoSmithKline intends to work with researchers from University of North Carolina to set up a research institute.
A few decades ago, AIDS was regarded as one of the least mentioned medical issue among scientists. However, health experts are now pretty optimistic that it is a curable disease.
Currently, the disease is the second leading cause of death in the United States. According to the latest report from the World Health Organization, every year more than 50 thousand people suffer from AIDS. The disease kills nearly 1.5 million people only in the United States.
The institute will be set up near the North Caroline campus of Glaxosmith. The chief goal of the firm is to develop a proper AIDS treatment.
The pharmaceutical firm will pay a large sum of money for five years to the research institute. A few scientists of GlaxoSmith will also be moved to the new research center.
The company and the US researchers will equally own the new institute. The research center dubbed as Qura Therapeutics, can sale any treatment or drug.
This is not the first time when any firm has collaborated with university. Currently, Novartis is also working with the University of Pennsylvania. They will build a research center to genetically change immune cells. The primary objective is to fight against cancer.